InvestorsObserver
Sign Up Login

CPIX Cumberland Pharmaceu

$2.10 $0.09 (4.48%)
Add to Watchlist Compare
Overall

CPIX Stock Analysis Overview

What this means: InvestorsObserver gives Cumberland Pharmaceu (CPIX) an overall rank of 31, which is below average. Cumberland Pharmaceu is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. A rank of 31 means that 69% of stocks appear more favorable to our system.

Who this matters to: Overall Ranking is a comprehensive evaluation. It considers technical and fundamental factors and is a good starting point for evaluating a stock.

View Sample Report
Fundamental PREMIUM

CPIX Fundamental Analysis

Who this matters to: The Fundamental Ranking considers the health of the underlying company. It is best used by longer-term buy-and-hold investors.

Upgrade to Premium to unlock Fundamental Ranking

Short-Term Technical PREMIUM

CPIX Short-Term Technical Analysis

Who this matters to: The Short-Term Technical Ranking evaluates a stock’s trading over the past month. This is most useful for short- to medium-term stock and option traders.

Upgrade to Premium to unlock Short-Term Technical Ranking

Long-Term Technical PREMIUM

CPIX Long-Term Technical Analysis

Who this matters to: The Long-Term Technical Ranking is a good gauge of how a stock has traded over the past several months. This is useful for medium to long-term stock and option traders.

Upgrade to Premium to unlock Long-Term Technical Ranking

Analyst Ranking PREMIUM

CPIX Analyst Ranking

Who this matters to: Analyst Ranking shows you which stocks Wall Street analysts like the most. Since analysts build valuation models, this is most useful for medium to long-term investors who are interested in a valuation-based approach.

Upgrade to Premium to unlock Analyst Ranking Analysis

Valuation PREMIUM

CPIX Valuation Ranking Analysis

Who this matters to: Valuation Ranking is most-useful for value-focused investors who plan to hold a stock for the long term.

Upgrade to Premium to unlock Valuation Ranking

Stock Sentiment PREMIUM

CPIX Stock Sentiment Analysis

Who this matters to: Sentiment Rank looks at the past five trading days. This is our shortest-term evaluation and is best used by people with a very short horizon.

Upgrade to Premium to unlock Stock Sentiment Ranking

CPIX Stock Analysis Overview

What this means: InvestorsObserver gives Cumberland Pharmaceu (CPIX) an overall rank of 31, which is below average. Cumberland Pharmaceu is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. A rank of 31 means that 69% of stocks appear more favorable to our system.

Who this matters to: Overall Ranking is a comprehensive evaluation. It considers technical and fundamental factors and is a good starting point for evaluating a stock.

Create a FREE account to see full CPIX report

CPIX Fundamental Analysis

Who this matters to: The Fundamental Ranking considers the health of the underlying company. It is best used by longer-term buy-and-hold investors.

Upgrade to Premium to unlock Fundamental Ranking

CPIX Short-Term Technical Analysis

Who this matters to: The Short-Term Technical Ranking evaluates a stock’s trading over the past month. This is most useful for short- to medium-term stock and option traders.

Upgrade to Premium to unlock Short-Term Technical Ranking

CPIX Long-Term Technical Analysis

Who this matters to: The Long-Term Technical Ranking is a good gauge of how a stock has traded over the past several months. This is useful for medium to long-term stock and option traders.

Upgrade to Premium to unlock Long-Term Technical Ranking

CPIX Analyst Ranking

Who this matters to: Analyst Ranking shows you which stocks Wall Street analysts like the most. Since analysts build valuation models, this is most useful for medium to long-term investors who are interested in a valuation-based approach.

Upgrade to Premium to unlock Analyst Ranking Analysis

CPIX Valuation Ranking Analysis

Who this matters to: Valuation Ranking is most-useful for value-focused investors who plan to hold a stock for the long term.

Upgrade to Premium to unlock Valuation Ranking

CPIX Stock Sentiment Analysis

Who this matters to: Sentiment Rank looks at the past five trading days. This is our shortest-term evaluation and is best used by people with a very short horizon.

Upgrade to Premium to unlock Stock Sentiment Ranking

Cumberland Pharmaceu (CPIX) Analyst Forecast

CPIX Price, Volume, Earnings, and Dividend Date

  • Last Price $2.10
  • Previous Close $2.01
  • Change $0.09
  • Open $2.06
  • Volume 2,704
  • Avg. Volume (100-day) 32,657
  • Market Cap 31,009,633
  • Days Range 2.05 - 2.1399
  • 52-week Range 1.89 - 7.51
  • Dividend Yield —
  • Ex. Dividend Date —
  • P-E —
  • EPS —
  • Earnings Date 08/09/22
  • Sector Healthcare
  • Industry Drug Manufacturers - Specialty & Generic
  • Avg. Analyst Rec. Premium
  • Beta 0.183
  • PEG Ratio —

Cumberland Pharmaceu (CPIX) Company Description

Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development and commercialization of branded prescription pharmaceutical products. The company's primary target markets are hospital acute care, gastroenterology, rheumatology and oncology. The company promotes its approved products through its hospital, field and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived primarily from the product sales of FDA approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, RediTrex, Sancuso, Vaprisol and Vibativ..

Cumberland Pharmaceu (CPIX) Stock Chart

View Interactive CPIX chart

My Watchlists

Follow Your Favorite Stocks

Top Stocks in Drug Manufacturers - Specialty & Generic

Company Price
Assertio Therapeutics Inc (ASRT) (ASRT) $2.73
Optinose Inc (OPTN) (OPTN) $3.76
Dynavax Technologies (DVAX) (DVAX) $12.33
Cardiol Therapeutics (CRDL) (CRDL) $1.48
Catalent Inc (CTLT) (CTLT) $109.61
Painreform Ltd (PRFX) (PRFX) $0.99
Intercure Ltd (INCR) (INCR) $6.05
Evolus Inc (EOLS) (EOLS) $12.78
Harrow Health Inc (HROW) (HROW) $7.07
Deciphera Pharmaceuticals Inc (DCPH) (DCPH) $13.73